Overtime: How I’m fighting to Cure My Disease When Every Second Counts
I titled my post “Overtime,” because I have considered myself in overtime ever since November 2010 when I had my...
Dr. David Fajgenbaum, MD, MBA, MSc, is the co-founder and Executive Director for the Castleman Disease Collaborative Network (CDCN), an Assistant Professor of Medicine in the Division of Translational Medicine & Human Genetics at the University of Pennsylvania, and the Associate Director, Patient Impact for the Penn Orphan Disease Center. Forbes Magazine recognized Dr. Fajgenbaum on the 2015 30 Under 30 Healthcare list. Learn more about the Castleman Disease Collaborative Network and how you can donate to their research or join their leadership team at http://www.cdcn.org.
I titled my post “Overtime,” because I have considered myself in overtime ever since November 2010 when I had my...
Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2025 IMPAKTER. All rights reserved.